Günter Rapatz

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

Roger Bullock, Jacques Touchon, Howard Bergman et al. · Current Medical Research and Opinion · 2005 · 230 citations

Medicine, Pharmacology, Pharmacotherapy +12

Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease

Rafael Blesa, Roger Bullock, Yunsheng He et al. · Pharmacogenetics and Genomics · 2006 · 65 citations

Medicine, Pharmacology, Pharmacotherapy +17

Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology

Jacques Touchon, Howard Bergman, Roger Bullock et al. · Current Medical Research and Opinion · 2005 · 54 citations

Medicine, Neurology, Pharmacotherapy +17

Faster Onset of Bronchodilation with Formoterol than with Salmeterol in Patients with Stable, Moderate‐Severe Copd: Results of a Randomized, Double‐Blind Clinical Study

John Kottakis, Giovanni Della Cioppa, Jacques P.H.M. Creemers et al. · Canadian Respiratory Journal · 2002 · 49 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17